Medtech innovator accelerates R&D and manufacture of groundbreaking cancer treatment after Analysis for Innovators (A4I) funding
LightOx’s light-activated solution is the first of its kind in the UK A medtech innovator has accelerated its R&D and manufacture of its groundbreaking cancer treatment, after funding from Innovate UK’s Analysis for Innovators (A4I) programme. LightOx, based in Newcastle, has developed a UK-first solution for early-stage mouth cancers using light-activated chemotherapy. The treatment involves […]
Continue Reading